Illumina Inc (ILMN)

ILMN (NASDAQ:Drugs)
$164.47
neg -0.44
-0.27%
Today's Range: 161.00 - 166.00 | ILMN Avg Daily Volume: 1,130,300
Last Update: 10/20/14 - 4:00 PM EDT
Volume: 1,876,543
YTD Performance: 48.72%
Open: $165.58
Previous Close: $164.91
52 Week Range: $80.88 - $185.00
Oustanding Shares: 139,400,000
Market Cap: 22,988,454,000
6-Month Chart
TheStreet Ratings Grade for ILMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 10 10 9
Moderate Buy 0 0 0 0
Hold 7 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.78 1.89 1.89 1.94
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 109.21
Price Earnings Comparisons:
ILMN Sector Avg. S&P 500
109.21 109.40 27.19
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.50% 101.98% 511.41%
GROWTH 12 Mo 3 Yr CAGR
Revenue 23.70 0.57 0.16
Net Income -17.20 0.00 0.00
EPS -20.90 -0.01 0.00
Earnings for ILMN:
EBITDA 0.26B
Revenue 1.42B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.64 $0.66 $2.30 $2.82
Number of Analysts 12 7 14 14
High Estimate $0.68 $0.72 $2.36 $3.01
Low Estimate $0.60 $0.61 $2.26 $2.71
Prior Year $0.45 $0.53 $1.80 $2.30
Growth Rate (Year over Year) 41.85% 24.53% 27.50% 22.91%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bullishIllumina estimates, target raised at JMP

Oct 21, 2014 | 7:13 AM EDT

Shares of ILMN now seen reaching $245, according to JMP Securities. Estimates also increased, as the company is seeing higher demand across the board. Outperform rating. 

bullishIllumina upgraded at Piper

Oct 16, 2014 | 8:09 AM EDT

ILMN was upgraded from Neutral to Overweight, Piper Jaffray said. $192 price target. Channel checks suggest accelerating demand for HiSeq X Ten.

By

Bret Jensen

 | Aug 26, 2014 | 11:45 AM EDT

Here are three stocks to avoid at current levels.

bullishIllumina upgraded at Wedbush

Aug 20, 2014 | 7:28 AM EDT

ILMN was upgraded from Neutral to Outperform, Wedbush said. $200 price target. Estimates also increased, following the recent Labcorp win.

bullishIllumina upgraded at Maxim

Apr 23, 2014 | 8:11 AM EDT

ILMN was upgraded from Hold to Buy, Maxim Group said. $205 price target. Clinical customers are accelerating adoption and the company is seeing better penetration of HiSeq X Ten.

 

By

Ed Ponsi

 | Mar 14, 2014 | 1:00 PM EDT

Let's review.

By

Chris Laudani

 | Mar 11, 2014 | 10:30 AM EDT

I'd wait until the stock cools off to buy shares.

By

Chris Laudani

 | Mar 6, 2014 | 11:30 AM EST

Its genetics work has the stock at crazy new heights

bullishIllumina price target, EPS bumped up at UBS

Feb 19, 2014 | 7:33 AM EST

ILMN raised its numbers through 2016, UBS said. Demand momentum and competitive position appear stronger than ever. $202 price target and Buy rating. 

bullishIllumina added to Focus List at JP Morgan

Jan 17, 2014 | 8:17 AM EST

ILMN was placed on the Focus List, JP Morgan said. $190 price target. Company will launch several new products this year. Overweight rating.

OK, this story is doing the rounds and cheering everyone up in Europe (and I suspect in th...
With overnight inventory being long, the Es currently trading above its low volume area of...
This is a quick review of where this bounce has taken the major indices. The DJIA is back ...
Looks like equities could have their second up day in a row to start the trading week as e...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.